Literature DB >> 2647836

Cryptococcosis.

J R Perfect1.   

Abstract

Cryptococcosis emphasizes the importance of the host-parasite interaction. C. neoformans has developed factors to invade the host but generally requires host immune dysfunction to establish infection. Cryptococcal infection has increased as our immunocompromised pool of patients enlarges. Although many questions regarding management of cryptococcosis remain, it is a well-studied infection with excellent guidelines for diagnosis, treatment, and prognosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647836

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  38 in total

1.  Cryptococcus neoformans mitochondrial genomes from serotype A and D strains do not influence virulence.

Authors:  Dena L Toffaletti; Kirsten Nielsen; Fred Dietrich; Joseph Heitman; John R Perfect
Journal:  Curr Genet       Date:  2004-08-07       Impact factor: 3.886

2.  Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens.

Authors:  W Gade; S W Hinnefeld; L S Babcock; P Gilligan; W Kelly; K Wait; D Greer; M Pinilla; R L Kaplan
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

Review 3.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.

Authors:  S M Levitz; M P Dupont
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule.

Authors:  A S Ibrahim; S G Filler; M S Alcouloumre; T R Kozel; J E Edwards; M A Ghannoum
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

6.  Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group.

Authors:  M E Brandt; L C Hutwagner; L A Klug; W S Baughman; D Rimland; E A Graviss; R J Hamill; C Thomas; P G Pappas; A L Reingold; R W Pinner
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

7.  Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro.

Authors:  M S Alcouloumre; M A Ghannoum; A S Ibrahim; M E Selsted; J E Edwards
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid.

Authors:  J R Perfect; D L Toffaletti; T H Rude
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States.

Authors:  Edmond J Byrnes; Wenjun Li; Yonathan Lewit; Hansong Ma; Kerstin Voelz; Ping Ren; Dee A Carter; Vishnu Chaturvedi; Robert J Bildfell; Robin C May; Joseph Heitman
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

10.  The Nramp orthologue of Cryptococcus neoformans is a pH-dependent transporter of manganese, iron, cobalt and nickel.

Authors:  Daniel Agranoff; Lauren Collins; David Kehres; Tom Harrison; Michael Maguire; Sanjeev Krishna
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.